DETALII PRODUS

Retatrutide

380 lei

Stoc epuizat

Retatrutide este un medicament, administrat prin injecție o dată pe săptămână, conceput pentru pierderea semnificativă în greutate și tratarea diabetului de tip 2.
Caracteristici cheie
  • Acțiune „Triple G”: Spre deosebire de medicamentele actuale care vizează unul sau doi hormoni (precum Ozempic sau Mounjaro), retatrutide imită trei hormoni diferiți care reglează foamea: GLP-1, GIP și glucagonul.
  • Potență: Deoarece vizează trei căi, primele studii clinice arată că ar putea fi mai eficient decât tratamentele actuale, unii participanți pierzând până la 24-30% din greutatea corporală pe parcursul a 48-68 de săptămâni.
  • Beneficii metabolice: Pe lângă suprimarea poftei de mâncare, acesta poate accelera metabolismul, îmbunătăți sensibilitatea la insulină și ajuta la reducerea grăsimii hepatice (de la nivelul ficatului).

Descrierea producatorului

Specifications Retatrutide:

Company: Hilma Biocare

Retatrutide (LY-3437943) is a drug intended for the treatment of obesity. It is a triple receptor agonist for GLP-1 (Glucagon-like peptide-1), GIP (Gastric inhibitory polypeptide, also known as glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). Retartrutide is a 39-amino acid peptide that is resistant to cleavage by DPP4, the enzyme that cleaves GLP-1 and GIP. Retartrutide is constructed from a GIP peptide backbone to achieve triple agonist activity against GLP-1R, GIP, and GCGR.

Indication

Treatment of type 2 diabetes mellitus and weight loss. Retartrutide is used to improve glycemic control in combination with diet and exercises.

Mechanism Of Action

Retatrutide exerts its therapeutic effect through several mechanisms.

  1. The drug mimics the GLP-1 hormone, which is naturally released after a meal. This hormone sends a satiety signal to the brain, helping to reduce appetite and prevent overeating. Thus, the first mechanism is that Retatrutide promotes a longer feeling of fullness.
  2. As a GLP-1 and GCGR agonist, Retatrutide enhances insulin release from the pancreas while simultaneously reducing glucagon release, which leads to an increase in blood sugar levels and stabilization of energy levels. Thus, the second mechanism can be described as stimulating metabolism: using the energy obtained from food for vital processes in the body instead of storing it as fat. This process ultimately leads to weight loss and may help lower blood pressure.
  3. Retatrutide prevents sharp drops in blood sugar levels, which often lead to food cravings and/or irregular eating habits, ultimately leading to overeating. This effect may make it easier to adhere to a weight loss plan and monitor a diet plan.

 

Clinical studies have shown that Retatrutide can lead to weight loss in as little as 4 weeks. Results from clinical trials demonstrate that in adults with obesity or overweight (non-diabetic) who are treated with Retatrutide, body weight loss can reach 15-35% after completion of treatment.

Protection code:

How it works:

product

Hilma Biocare™ takes care of consumers and regularly develops various means of protecting its products, which ensures patient safety and trust to verify our products

Package sizes:

 

Recenzii

Nu există recenzii până acum.

Fii primul care scrii o recenzie pentru „Retatrutide”

Adresa ta de email nu va fi publicată. Câmpurile obligatorii sunt marcate cu *

Stero Shop - Hilma Biocare™

Reactualizarea stocului are loc la sfârșitul lunii Aprilie, inclusiv pentru Primobolan si Retatrutide.